Tuesday, September 1, 2026

Korea Clears New Probiotic Claim: hy’s HY7017 Shows Immune Gains in Human Trials

hy's probiotic strain HY7017 has been approved for immune enhancement, adding to its portfolio of nine recognized ingredients.

THE CALIBER OF SUCCESSION : Why Ju Ae’s Finger On The Trigger Is A Message To The World

North Korean media highlights Ju-ae's military involvement, suggesting her emergence as a future leader alongside Kim Jong Un.

Moral SHAME: Lee Administration Sacrifices Human Life and Dignity Just To Appease A Tyrannical Regime

North Korean rights groups urge South Korea to co-sponsor a UN resolution, expressing concern over human rights under President Lee Jae Myung.

Tag: PARP inhibitors

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Next-Gen Cancer Drug Nesuparib: How It Outperforms Olaparib in SCLC and Pancreatic Cancer

Onconic Therapeutics will present Nesuparib research at AACR 2026, showcasing its potential for various cancers and overcoming PARP inhibitor limitations.

New Hope for Solid Tumors? Korean Biotech Starts Phase 1 Trial of Targeted Drug

Digmbio secures 12 billion KRW for clinical trials of cancer drug DM5167 and advances treatment for degenerative brain diseases.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.